Science has always battled with the question of nature vs nurture. Is it your genes which create you or is it your environment? The answer, unfortunately, is not so binary. Both…
The GPhC is now following suit with the CQC and openly publishing inspection data on https://inspections.pharmacyregulation.org/. It makes for a fascinating read why certain pharmacies do not meet the standards…
We had a few enquiries recently about whether pharmacists should start up an ear irrigation service. We did a little research and came across this BMJ article. Essentially Doctors do…
Cybersecurity is becoming a greater focal point of pharmacy organisations around the world. According to the Council of Small Business Organisations of Australia (COSBOA) 20 per cent of small businesses…
Major depressive disorder (MDD) is a significant cause of disability worldwide and the most common illness preceding suicide. On March 5, 2019, the nasal spray drug, esketamine, also known as Spravato (by Janssen…
Spravato is the brand name of esketamine, a glutamate receptor drug used for rapid depression treatment manufactured by Johnson & Johnson in the US. Esketamine is contained within the standard pharmaceutical…
Spravato is the brand name of esketamine, a nasally adminitsered medicine used for the rapid treatment of moderate to severe depression. Spravato was initially released by Johnson & Johnson in…
Risk assessment is at the core of what a pharmacist travel health clinician does. It is not just our job to analyse where the patient is going but multiple additional…
The General Pharmaceutical Council (GPhC), the regulator of pharmacists in the UK has convened to discuss how as a profession, pharmacists can reduce the barriers to entry for pharmacy graduates…